Toll-like receptor 2 contributes to liver injury by salmonella infection through Fas ligand expression on NKT cells in mice

被引:43
作者
Shimizu, H
Matsuguchi, T
Fukuda, Y
Nakano, I
Hayakawa, T
Takeuchi, O
Akira, S
Umemura, M
Suda, T
Yoshikai, Y
机构
[1] Nagoya Univ, Sch Med, Lab Host Def & Germfree Life, Dis Mechanism & Control Res Inst,Showa Ku, Nagoya, Aichi 4668550, Japan
[2] Nagoya Univ, Sch Med, Dept Internal Med 2, Nagoya, Aichi 4668550, Japan
[3] Osaka Univ, Dept Host Def, Microbial Dis Res Inst, Osaka, Japan
[4] Kanazawa Univ, Ctr Dev Mol Target Drugs, Inst Canc Res, Kanazawa, Ishikawa 920, Japan
关键词
D O I
10.1053/gast.2002.36006
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Toll-like receptors (TLRs) for bacterial constitutes are expressed not only by phagocytes but also by some subsets of T cells. We previously reported that natural killer T cells (NKT cells) play an, important role in liver injury induced by Salmonella infection. In the present study, we investigated whether TLRs on NKT cells are involved in Salmonella-induced liver injury. Methods: Gene express! on of TLR2 was examined in sorted natural killer, NKT, and T cells from livers of naive mice by the reverse-transcription polymerase chain reaction method. Serum alanine aminotransferase level and FasL expression on liver lymphocytes were examined in TLR2-deficient (TLR2(-/-)) and FasL-deficient gld/gld mice before and after intraperitoneal inoculation of Salmonella choleraesuis 31N-1 using an enzyme-linked immunosorbent assay and flow cytometry. Results: TLR2 gene was abundantly expressed by NKT cells freshly isolated from naive mice. FasL expression on liver NKT cells increased in TLR2(-/-) mice but not in TLR2(-/-) mice after Salmonella infection. Serum alanine aminotransferase level was significantly lower in the TLR2(-/-) and gld/gld mice than in the control mice after infection. Conclusions: TLR2 may contribute to liver injury induced by Salmonella infection via FasL induction on liver NKT cells.
引用
收藏
页码:1265 / 1277
页数:13
相关论文
共 64 条
[31]   Therapeutic effect of an anti-Fas ligand mAb on lethal graft-versus-host disease [J].
Miwa, K ;
Hashimoto, H ;
Yatomi, T ;
Nakamura, N ;
Nagata, S ;
Suda, T .
INTERNATIONAL IMMUNOLOGY, 1999, 11 (06) :925-931
[32]   T-CELL ACTIVATION-ASSOCIATED HEPATIC-INJURY - MEDIATION BY TUMOR NECROSIS FACTORS AND PROTECTION BY INTERLEUKIN-6 [J].
MIZUHARA, H ;
ONEILL, E ;
SEKI, N ;
OGAWA, T ;
KUSUNOKI, C ;
OTSUKA, K ;
SATOH, S ;
NIWA, M ;
SENOH, H ;
FUJIWARA, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (05) :1529-1537
[33]   Prostaglandin E1 protects against liver injury induced by Escherichia coli infection via a dominant Th2-like response of liver T cells in mice [J].
Mokuno, Y ;
Takano, M ;
Matsuguchi, T ;
Nishimura, H ;
Washizu, J ;
Naiki, Y ;
Nimura, Y ;
Yoshikai, Y .
HEPATOLOGY, 1999, 30 (06) :1464-1472
[34]   Expression of toll-like receptor 2 on γδ T cells bearing invariant Vγ6/Vδ1 induced by Escherichia coli infection in mice [J].
Mokuno, Y ;
Matsuguchi, T ;
Takano, M ;
Nishimura, H ;
Washizu, J ;
Ogawa, T ;
Takeuchi, O ;
Akira, S ;
Nimura, Y ;
Yoshikai, Y .
JOURNAL OF IMMUNOLOGY, 2000, 165 (02) :931-940
[35]   Interleukin-10 inhibits hepatic injury and tumor necrosis factor-α and interferon-γ mRNA expression induced by staphylococcal enterotoxin B or lipopolysaccharide in galactosamine-sensitized mice [J].
Nagaki, M ;
Tanaka, M ;
Sugiyama, A ;
Ohnishi, H ;
Moriwaki, H .
JOURNAL OF HEPATOLOGY, 1999, 31 (05) :815-824
[36]   Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-γ-dependent mechanism [J].
Nicoletti, F ;
Di Marco, R ;
Zaccone, P ;
Salvaggio, A ;
Magro, G ;
Bendtzen, K ;
Meroni, P .
HEPATOLOGY, 2000, 32 (04) :728-733
[37]   LETHAL EFFECT OF THE ANTI-FAS ANTIBODY IN MICE [J].
OGASAWARA, J ;
WATANABEFUKUNAGA, R ;
ADACHI, M ;
MATSUZAWA, A ;
KASUGAI, T ;
KITAMURA, Y ;
ITOH, N ;
SUDA, T ;
NAGATA, S .
NATURE, 1993, 364 (6440) :806-809
[38]  
Ogasawara K, 1998, J IMMUNOL, V160, P3522
[39]  
Osman Y, 2000, EUR J IMMUNOL, V30, P1919, DOI 10.1002/1521-4141(200007)30:7<1919::AID-IMMU1919>3.0.CO
[40]  
2-3